Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | GRM5 | P41594 | 5/20 | 0.44 |
| ▸ | APP | P05067 | 3/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.36 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2707919 | 0.84 | PDE4D (0.43) | MAPTMEN1KMT2AKDM4ELMNA | |
| SCHEMBL3136635 | 0.83 | MAPT (0.47) | MAPTMEN1KMT2AKDM4ELMNA | |
| SCHEMBL3155270 | 0.83 | MAPT (0.47) | MAPTMEN1KMT2AKDM4ELMNA | |
| SCHEMBL3150217 | 0.83 | MAPT (0.47) | MAPTMEN1KMT2AKDM4ELMNA | |
| SCHEMBL3675046 | 0.81 | ESR1 (0.41) | MAPTMEN1KMT2AKDM4ELMNA | |
| SCHEMBL18184907 | 0.80 | PDE4D (0.50) | MAPTMEN1KMT2AKDM4ELMNA | |
| SCHEMBL3142132 | 0.79 | MAPT (0.44) | MAPTMEN1KMT2AKDM4ELMNA | |
| SCHEMBL3146501 | 0.79 | MAPT (0.50) | MAPTMEN1KMT2AKDM4ELMNA | |
| SCHEMBL2709285 | 0.77 | PDE4D (0.43) | GRM5PDE4D | |
| SCHEMBL940463 | 0.76 | SMN1; SMN2 (0.59) | MAPTMEN1KMT2AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8722842-B2 | Optical film and image display device | NITTO DENKO CORPORATION (JP) | 2014-05-13 | — | — | US | disclosed |
| US-8218937-B2 | Optical film, image display device, diethynylfluorene, and polymer thereof | NITTO DENKO CORPORATION (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100110554-A1 | OPTICAL FILM AND IMAGE DISPLAY DEVICE | NITTO DENKO CORPORATION (JP) | 2010-05-06 | — | — | US | disclosed |
| US-20100003490-A1 | OPTICAL FILM, IMAGE DISPLAY DEVICE, DIETHYNYLFLUORENE, AND POLYMER THEREOF | NITTO DENKO CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100003490-A1 | OPTICAL FILM, IMAGE DISPLAY DEVICE, DIETHYNYLFLUORENE, AND POLYMER THEREOF | PDCD2L, FMNL1, MACF1 | MAPT 250/4885MEN1 1959/4885KMT2A 2376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.